Prostate Cancer International is
for 2011 by Great NonProfits
As one might expect, there is an extremely diverse (and conflicting) range of reactions to the USPSTF recommendation that routine PSA testing of uninformed men is not supported by good evidence and should no longer be considered as appropriate “standard” practice unless there has been a prior discussion of the risks and benefits of the [...]
Filed under: Diagnosis, Management, Risk | Tagged: benefit, cost, coverage, PSA, risk, USPSTF | 6 Comments »
The media – over the past few days — has taken every opportunity to “stoke the furore” about the USPSTF’s recommendation that PSA screening (of all men aged 50 to 75 years of age, or thereabouts) is not justified by the available data.
Filed under: Diagnosis, Management, Risk | Tagged: PSA, risk, testing, USPSTF | 3 Comments »
The “New” Prostate Cancer InfoLink has replicated below, in its entirety, a media release issued early this morning by the Prostate Cancer Foundation. We believe that this is precisely the correct response to the new USPSTF recommendation: acknowledgement of the realities of the USPSTF’s factually accurate recommendation and the recognition by the USPSTF that PSA [...]
Filed under: Diagnosis, Management, Risk | Tagged: screening, USPSTF, testing, Prostate cancer Foundation, PCF | 5 Comments »
Whatever we may think individually about the recent decision by the U.S. Preventive Services Task Force to recommend against the use of PSA testing as a means of “screening” for risk of prostate cancer, we would be wise to understand that at the heart of this decision is poor science.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: PSA, risk, screening, survival, USPSTF | 29 Comments »
The U.S. Preventive Services Task Force (USPSTF) — after previously stating that it would be releasing its new recommendations about PSA testing for risk of prostate cancer on Tuesday next week — has been pressured (by a variety of organizations, and by the media) to release its draft recommendation today.
Filed under: Diagnosis, Risk | Tagged: Diagnosis, PSA, risk, testing, USPSTF | 14 Comments »
According to a story on today’s Wall Street Journal Health Blog, the U.S. Preventive Services Task Force (USPSTF) has canceled a meeting originally scheduled for November 1-2, when it was expected to re-vote on recommendations regarding the use of prostate cancer screening.
Filed under: Uncategorized | Tagged: recommendation, risk, screening, USPSTF | 2 Comments »
Apparently the U.S. Preventive Services Task Force (USPSTF) has learned a little about communications from the chaos that accompanied the announcement of new guidelines for breast cancer screening in November 2009.
Filed under: Diagnosis, Risk | Tagged: screening, U.S. Preventive Services Task Force, USPSTF | 2 Comments »
The recommendations of the U.S. Preventive Services Task Force (USPSTF) about cancer screening continue to come under direct political fire from Capitol Hill — and this is probably not a very constructive idea.
Filed under: Diagnosis, Prevention, Risk | Tagged: screening, testing, USPSTF | 1 Comment »
Other news reports today — from sources not related to the ASTRO annual meeting — address such topics as: Perceptions about the US Preventive Services Task Force recommendations regarding the use of PSA testing men men > 75 years Renal insufficiency in men of long-term drug therapy for prostate cancer Cetuximab + doxirubicin in the [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: cetruximab, doxirubicin, estrogen, PSA testing, renal in sufficiency, USPSTF | Leave a Comment »
The Washington Post today published an opinion piece by William Catalona, MD strongly criticizing the recent update to the US Preventive Services Task Force’s guidelines on screening for prostate cancer.
Filed under: Diagnosis | Tagged: Catalona, guidelines, USPSTF | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site